ORCID as entered in ROS

Select Publications
2023, 'Plasma arginine metabolites in health and chronic kidney disease', NEPHROLOGY DIALYSIS TRANSPLANTATION, http://dx.doi.org/10.1093/ndt/gfad108
,2023, 'Electronic alerts and a care bundle for acute kidney injury-an Australian cohort study', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 38, pp. 610 - 617, http://dx.doi.org/10.1093/ndt/gfac155
,2023, 'WCN23-0928 URINARY AND PLASMA BIOMARKER PANEL FOR EARLY DETECTION OF ACUTE KIDNEY INJURY (AKI) AND PROGNOSTIC STRATIFICATION', Kidney International Reports, 8, pp. S36 - S36, http://dx.doi.org/10.1016/j.ekir.2023.02.082
,2022, 'Cystatin C kidney functional reserve: a simple method to predict outcome in chronic kidney disease', Nephrology Dialysis Transplantation, 37, pp. 1118 - 1124, http://dx.doi.org/10.1093/ndt/gfab188
,2021, 'The kinetic estimated glomerular filtration rate ratio predicts acute kidney injury', Nephrology, 26, pp. 782 - 789, http://dx.doi.org/10.1111/nep.13918
,2021, 'Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer', Blood Advances, 5, pp. 487 - 495, http://dx.doi.org/10.1182/bloodadvances.2020003149
,2021, 'OC-11 Plasminogen activator inhibitor 1 enhances venous thrombosis in pancreatic cancer', Thrombosis Research, 200, pp. S10 - S11, http://dx.doi.org/10.1016/s0049-3848(21)00153-5
,2020, 'Targeted protection of proximal tubular cells by nanoparticle-enhanced delivery of a TLR9-antagonist', Kidney International, 98, pp. 48 - 50, http://dx.doi.org/10.1016/j.kint.2020.04.024
,2020, 'Hyponatraemia in heart failure', Internal Medicine Journal, 50, pp. 659 - 666, http://dx.doi.org/10.1111/imj.14624
,2020, 'Selection and validation of reference genes for normalisation of gene expression in ischaemic and toxicological studies in kidney disease', PLoS ONE, 15, pp. e0233109, http://dx.doi.org/10.1371/journal.pone.0233109
,2020, 'Acute kidney injury following intravenous acyclovir in children', Archives of Disease in Childhood, 31, pp. 1899 - 1899, http://dx.doi.org/10.1136/archdischild-2019-317990
,2020, 'P166 Urinary biomarkers of kidney injury in children with cystic fibrosis', Journal of Cystic Fibrosis, 19, pp. S103 - S103, http://dx.doi.org/10.1016/s1569-1993(20)30501-4
,2020, 'WS04.5 Urinary clusterin in children with cystic fibrosis: a novel biomarker of lung disease?', Journal of Cystic Fibrosis, 19, pp. S7 - S8, http://dx.doi.org/10.1016/s1569-1993(20)30187-9
,2019, 'Advances in Detection of Kidney Transplant Injury', Molecular Diagnosis and Therapy, http://dx.doi.org/10.1007/s40291-019-00396-z
,2019, 'SUN-203 Inflammatory cytokines detect superimposed brief ischaemia in the presence of subclinical chronic kidney disease (sCKD).', Kidney International Reports, 4, pp. S243 - S243, http://dx.doi.org/10.1016/j.ekir.2019.05.606
,2018, 'The uremic solute-AHR-tissue factor axis in vascular cells, mouse models and thrombosis in chronic kidney disease patients', ANNALS OF TRANSLATIONAL MEDICINE, 6, http://dx.doi.org/10.21037/atm.2018.04.27
,2016, 'Paternal high fat diet in rats leads to renal accumulation of lipid and tubular changes in adult offspring', Nutrients, 8, http://dx.doi.org/10.3390/nu8090521
,2016, 'Cardiovascular risk reduction in hypertension: Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?', Internal Medicine Journal, 46, pp. 364 - 372, http://dx.doi.org/10.1111/imj.12975
,2014, 'TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE -/- mice', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0092952
,2014, 'How do clinical and psychological variables relate to quality of life in end-stage renal disease? Validating a proximal-distal model.', Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 23, pp. 677 - 686, http://dx.doi.org/10.1007/s11136-013-0499-1
2013, 'ACEIs for cardiovascular risk reduction: Have we taken our eye off the ball?', Australian Family Physician, 42, pp. 634 - 638
,2013, 'ACEIs for cardiovascular risk reduction Have we taken our eye off the ball?', AUSTRALIAN FAMILY PHYSICIAN, 42, pp. 634 - 638, http://search.informit.com.au/documentSummary;dn=537302915216331;res=IELHEA
,2012, 'Adjunctive ultrasonography during carotid artery stenting to minimize iodine contrast use.', Journal of Clinical Ultrasound, 41, pp. 323 - 326, http://dx.doi.org/10.1002/jcu.21902
,2012, 'The psychosocial correlates of quality of life in the dialysis population: a systematic review and meta-regression analysis', Quality of Life Research, 21, pp. 563 - 580, http://dx.doi.org/10.1007/s11136-011-9973-9
,2011, 'Measuring Kidney-Disease-Related Loss in the samples of pre-dialysis and dialysis patients: Validating the Kidney Disease Loss Scale, Clinical Journal of the American Society of Nephrology', Clinical Journal of the American Society of Nephrology, 5, pp. 1249 - 1254, http://dx.doi.org/10.2215/CJN.08361109
,2011, 'Psychosocial risk and protective factors for depression in the dialysis population: A systematic review and meta-regression analysis', Journal of Psychosomatic Research, 71, pp. 300 - 310, http://dx.doi.org/10.1016/j.jpsychores.2011.05.002
,2011, 'Studying psychosocial adaptation to end-stage renal disease: The proximal-distal model of health-related outcomes as a base model', Journal of Psychosomatic Research, 70, pp. 455 - 464, http://dx.doi.org/10.1016/j.jpsychores.2010.11.005
,2010, 'INTEGRATING CLINICAL VARIABLES, HEALTH OUTCOMES AND QUALITY OF LIFE IN END-STAGE RENAL DISEASE: THE PROXIMAL-DISTAL MODEL OF HEALTH-RELATED OUTCOMES', NEPHROLOGY, 15, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700185&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'THE CONTRIBUTION OF EGR-1 TO RENAL INJURY FOLLOWING RENAL ISCHAEMIA AND REPERFUSION INJURY IS DEPENDENT ON PAR-1', NEPHROLOGY, 15, pp. 90 - 90, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700245&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Measuring Kidney-Disease-Related Loss in the samples of pre-dialysis and dialysis patients: Validating the Kidney Disease Loss Scale', Clinical Journal of the American Society of Nephrology, 5, pp. 1249 - 1254
,2009, 'The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator', Clinical Journal of the American Society of Nephrology, 4, pp. 160 - 167
,2009, 'The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator', Clinical Journal of the American Society of Nephrology, 4, pp. 160 - 167, http://dx.doi.org/10.2215/CJN.01520308
,2008, 'Cardiac tissue factor: Roles in physiology and fibrosis', Clinical and Experimental Pharmacology and Physiology, 35, pp. 342 - 348, http://dx.doi.org/10.1111/j.1440-1681.2007.04872.x
,2008, 'Murine renal ischaemia-reperfusion injury', Nephrology, 13, pp. 390 - 396, http://dx.doi.org/10.1111/j.1440-1797.2008.00979.x
,2007, 'THE PROTEASE ACTIVATED RECEPTOR 1 INHIBITOR SCH79797 PROTECTS AGAINST RENAL ISCHAEMIA REPERFUSION INJURY', NEPHROLOGY, 12, pp. A16 - A16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'THE ROLE OF KIDNEY DISEASE RELATED LOSS IN DIALYSIS PATIENTS' QUALITY OF LIFE: DEPRESSION AND POSITIVE AFFECT AS MEDIATING FACTORS', NEPHROLOGY, 12, pp. A6 - A6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'The development of cardiac fibrosis in low tissue factor mice is gender-dependent and is associated with differential regulation of urokinase plasminogen activator', Journal of Molecular and Cellular Cardiology, 42, pp. 559 - 571, http://dx.doi.org/10.1016/j.yjmcc.2006.11.017
,2007, 'Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury', Blood, 109, pp. 577 - 583, http://dx.doi.org/10.1182/blood-2006-03-008870
,2006, 'INCREASED EXPRESSION OF PIGMENT EPITHELIUM-DERIVED FACTOR IN TUBULO-INTERSTITIAL FIBROSIS', NEPHROLOGY, 11, pp. A7 - A7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'Atherosclerosis in mice is not affected by a reduction in tissue factor expression', Arteriosclerosis, Thrombosis and Vascular Biology, 26, pp. 555 - 562, http://dx.doi.org/10.1161/01.ATV.0000202028.62414.3c
,2006, 'INTRAGRAFT GENE EXPRESSION PROFILING ASSOCIATED WITH TOLERANCE INDUCTION USING LENTIVIRAL-VECTOR MEDIATED GENE TRANSFER.', Transplantation, 82, pp. 1049 - 1049, http://dx.doi.org/10.1097/00007890-200607152-02990
,2005, 'Insulin resistance and postprandial triglyceride levels in primary renal disease', Metabolism - Clinical and Experimental, 54, pp. 821 - 828, http://dx.doi.org/10.1016/j.metabol.2005.01.028
,2004, 'Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: Lessons from low tissue factor mice', Thrombosis and Haemostasis, 92, pp. 444 - 450, http://dx.doi.org/10.1160/TH04-05-0309
,2004, 'Goodpasture's disease: Antiglomerular basement membrane disease', Nephrology, 9, pp. 49 - 51, http://dx.doi.org/10.1111/j.1440-1797.2004.00244.x
,2004, 'The cytoplasmic domain of tissue factor contributes to leukocyterecruitment and death in endotoxemia', American Journal of Pathology, 165, pp. 331 - 340, http://dx.doi.org/10.1016/S0002-9440(10)63300-7
,2003, 'PAR-1 signalling contributes to renal dysfunction and to the regulationof tissue factor expression following renal ischaernia reperfusioninjury', Journal of the American Society of Nephrology, 14, pp. 626A - 626A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186219102899&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2003, 'The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia', Journal of Thrombosis and Haemostasis, 1, pp. P0526 - P0526, http://dx.doi.org/10.1111/j.1538-7836.2003.tb04442.x
,2002, 'Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction', Proceedings of the National Academy of Sciences of the United States of America, 99, pp. 15333 - 15338, http://dx.doi.org/10.1073/pnas.242501899
,2001, 'Complement in renal disease', Nephrology, 6, pp. 145 - 154, http://dx.doi.org/10.1046/j.1440-1797.2001.00057.x
,2001, 'Complement in renal disease', Nephrology, 6, pp. 298 - 298, http://dx.doi.org/10.1046/j.1440-1797.2001.00085.x
,